{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Lung cancer",
      "differential diagnosis",
      "immunotherapy",
      "pneumonitis"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32842909",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/0300891620951863"
    ],
    "Journal": {
      "ISSN": "2038-2529",
      "JournalIssue": {
        "Volume": "107",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun"
        }
      },
      "Title": "Tumori",
      "ISOAbbreviation": "Tumori"
    },
    "ArticleTitle": "Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.",
    "Pagination": {
      "StartPage": "267",
      "EndPage": "269",
      "MedlinePgn": "267-269"
    },
    "Abstract": {
      "AbstractText": [
        "In this coronavirus 2019 (COVID-19) era, when pneumonitis occurs in patients with lung cancer receiving immune checkpoint inhibitors (ICIs), a major challenge is to make a rapid and correct differential diagnosis among drug-induced pulmonary toxicity, tumour progression, and severe acute respiratory syndrome coronavirus 2\u2009(SARS-CoV-2)-induced pneumonitis. While waiting for polymerase chain reaction (PCR) testing results, an accurate evaluation of the symptoms and serologic features can help us make\u2009a\u2009first\u2009diagnostic\u2009hypothesis and quickly start correct treatment. Physicians need a collaborative effort to develop and share a common database reporting clinical (anosmia, dysgeusia), serologic, and radiologic data in ICI-treated patients with lung cancer developing interstitial disease to create an evidence-based clinical diagnostic algorithm. This tool will continue to be helpful when we emerge from the pandemic crisis into a world in which COVID-19 may not have been eradicated to better select the target population requiring the most resource-consuming PCR tests."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-6767-1958"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Catania",
        "ForeName": "Chiara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Stati",
        "ForeName": "Valeria",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy."
          }
        ],
        "LastName": "Spitaleri",
        "ForeName": "Gianluca",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Tumori",
    "NlmUniqueID": "0111356",
    "ISSNLinking": "0300-8916"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Algorithms"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Immunotherapy"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Lung Diseases, Interstitial"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Pneumonia"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}